Navigation Links
BioMarin Announces Third Quarter 2008 Financial Results
Date:10/28/2008

Well-Positioned for Continued Long-Term Growth Conference Call and Webcast to Be Held Today at 5:00 p.m. ET (22:00 CET)
NOVATO, Calif., Oct. 28 /PRNewswire-FirstCall/ --

Financial Highlights ($ in millions, except per share data)

Item Q3 2008 Q3 2007 Comparison

Total BioMarin Revenue $72.6 190.5% increase

Naglazyme Net

Product Revenue $33.3 56.3% increase

Aldurazyme Net Sales

by Genzyme $38.2 18.3% increase

Aldurazyme BioMarin

Net Product Revenue $20.7 NA

Kuvan Net Product

Revenue $13.8 NA

GAAP Net Income (Loss) $0.8, $0.01 per share ($5.2), ($0.05) per share

Non-GAAP Net Income

(Loss) $8.2, $0.08 per share ($0.2), ($0.00) per share

2008 Guidance Unchanged ($ in millions)

Item Guidance

Total BioMarin Revenues* $288 to $326

Total Net Product Revenues $247 to $285

Naglazyme Net Product Revenue $130 to $140

Aldurazyme Net Product Sales by Genzyme $135 to $145

Aldurazyme Net Product Revenue to BioMarin $72 to $80

Kuvan Net Product Revenue $45 to $65

Net Income (GAAP)* $30 to $42

Net Income (non-GAAP)* $54 to $69

*Assumes that the $30 million milestone for EU Kuvan approval will be earned in 2008

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced financial results for the third quarter ended Septembe
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. BioMarin Corrects Information Included in Bloomberg Article
2. BioMarin to Present at the Merrill Lynch Global Pharmaceutical Conference
3. BioMarin to Present at the Morgan Stanley Global Healthcare Conference
4. BioMarin to Present at the Citi Biotech Day
5. BioMarin Announces Roll-Out of National PKU Registry
6. BioMarin to Host Second Quarter 2008 Financial Results Conference Call and Webcast on Tuesday, August 5 at 5:00 p.m. ET (23:00 CET)
7. BioMarin to Present at the Collins Stewart Growth Conference
8. SciQuest Announces Newest Life Sciences Customer; BioMarin Pharmaceutical Drives Spending Effectiveness with Automated, Intuitive Procurement
9. BioMarin Announces Program for ERT for Treatment of MPS IVA - Morquio A Syndrome
10. BioMarin to Host Research and Development Day June 5th
11. BioMarin to Present at the Bank of America Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... July 25, 2014 According to a ... Drugs Market - Global Industry Analysis, Size, Share, Growth, ... drugs market is estimated at USD 161,056.5 million in ... of 10.1% from 2014 to 2020, to reach an ... The biological drugs market is witnessing a significant growth ...
(Date:7/25/2014)... 25, 2014 The Conferee Networking committee ... for Conferee Networking. These two-hour sessions provide a unique ... and resolve problems, discuss new techniques, or brainstorm new ... submit a topic for consideration is August 31, 2014, ... The Conferee Networking committee will review the topics, and ...
(Date:7/25/2014)... AVIV, Israel , July 25, 2014  Galmed ... clinical-stage biopharmaceutical company focused on the development and commercialization ... liver diseases and cholesterol gallstones, today announced financial results ... First Half 2014 Financial Summary: , Reported cash ... 2014, compared with $137,000 at December 31, 2013.  ...
(Date:7/25/2014)... July 25, 2014 At the request ... granted a 60-day extension for the public comment period ... Rule for Model Aircraft established by Congress as part ... The 60-day extension establishes the new deadline for comments ... Department of Transportation/FAA notice published in the Federal Register ...
Breaking Biology Technology:Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Pittcon 2015 Announces Call for Topics for Conferee Networking Sessions 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6FAA Grants Comment Extension at the Request of AMA 2
... Oct. 7 Sydney-based Clinical Genomics Pty Ltd and ... collaboration to develop improved diagnostics for cancers of the ... research program, Clinical Genomics and researchers from CSIRO,s Preventative ... a number of biomarker genes capable of differentiating between ...
... ... Mass., and Applied CleanTech, based in Israel, today announced that they ... agricultural liquid waste into ethanol fuel for cars. Joint use of ... found to boost ethanol production, address sewage sludge disposal problems, and ...
... Pa., Oct. 6 Isolagen, Inc. has reorganized ... (OTC Bulletin Board: FCSC), a biotechnology company focused ... and scientific applications. The Company has named a ... Administration (FDA) is currently reviewing the biologics license ...
Cached Biology Technology:Clinical Genomics Continues Collaborative Research With CSIRO 2Cellulose from Wastewater Can Now be Turned into Fuel for Cars 2Cellulose from Wastewater Can Now be Turned into Fuel for Cars 3Cellulose from Wastewater Can Now be Turned into Fuel for Cars 4Isolagen, Inc. Reorganizes as Fibrocell Science, Inc. 2Isolagen, Inc. Reorganizes as Fibrocell Science, Inc. 3Isolagen, Inc. Reorganizes as Fibrocell Science, Inc. 4
(Date:7/28/2014)... wild relative of the domestic tomato, has been published ... headed by Professors Neelima Sinha and Julin Maloof at ... genome information may help breeders produce tastier, more stress-tolerant ... journal Nature Genetics , was lead by Bjrn ... UC Davis labs carried out work on the transcriptome ...
(Date:7/28/2014)... no cure for Alzheimer,s disease and other forms of ... to finding treatment. , University of Washington bioengineers have ... harmful changes of the body,s normal proteins into a ... Parkinson,s, heart disease, Type 2 diabetes and Lou Gehrig,s ... shift from their normal state into an abnormally folded ...
(Date:7/28/2014)... New research has identified areas of the Earth that ... climate change. , Europe is particularly vulnerable, as it ... four per cent, of any continent in ,refugia, ... natural environmental conditions remain relatively constant during times of ... Europe are mostly in Scandinavia and Scotland. , ...
Breaking Biology News(10 mins):New protein structure could help treat Alzheimer's, related diseases 2New protein structure could help treat Alzheimer's, related diseases 3Study finds Europe's habitat and wildlife is vulnerable to climate change 2
... show a combination of depressive symptoms and elevated levels of ... likely to develop major depression than those who show neither ... In a study published today in the Proceedings ... University of Cambridge have identified the first biomarker a ...
... non-coding RNAs can be used to predict if individuals ... Cancer Genome Atlas project. The results, which are published ... the levels of specific types of non-coding RNAs can ... These RNAs can also be used to classify cancer ...
... cancers so difficult to treat is that malignant cells from ... and blood vessels to invade new locations. Now, researchers have ... cancer by using a film of nanofibers thinner than human ... invading new areas, the migrating cells latch onto the specially-designed ...
Cached Biology News:First biological marker for major depression could enable better diagnosis and treatment 2First biological marker for major depression could enable better diagnosis and treatment 3First biological marker for major depression could enable better diagnosis and treatment 4Small non-coding RNAs could be warning signs of cancer 2Researchers hijack cancer migration mechanism to 'move' brain tumors 2Researchers hijack cancer migration mechanism to 'move' brain tumors 3Researchers hijack cancer migration mechanism to 'move' brain tumors 4
Troponin I (22B11)...
... low temperature freezers offer a superior ... of biological samples with high capacities. ... inner doors ensure excellent warming protection ... ,Application oriented accessories simplify tracking of ...
Chicken polyclonal to UCK2 ( Abpromise for all tested applications). Antigen: Full length protein, corresponding to amino acids 1-261 of Human UCK2 Entrez Gene ID: 7371 Swiss Protein ID: ...
Thermo Labsystems offers a basic reader for 96-well microplates that is especially adapted for ELISA and other colorimetric assays....
Biology Products: